Real-time enrollment status for this pulmonary arterial hypertension (pah) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:34 PM UTC
| NCT Number | NCT07759804 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Arterial Hypertension (PAH) |
| Phase | PHASE4 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Liquidia Technologies, Inc. |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07759804 is currently recruiting participants. This phase4 study for pulmonary arterial hypertension (pah) is actively seeking new participants at 1 location across the United States. The study is sponsored by Liquidia Technologies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07759804 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07759804 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.